• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一项开放性队列研究中预测2型糖尿病晚期并发症发生情况的多州模型

Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study.

作者信息

Aliyari Roqayeh, Hajizadeh Ebrahim, Aminorroaya Ashraf, Sharifi Farshad, Kazemi Iraj, Baghestani Ahmad-Reza

机构信息

Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.

Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

出版信息

Diabetes Metab Syndr Obes. 2020 May 28;13:1863-1872. doi: 10.2147/DMSO.S234563. eCollection 2020.

DOI:10.2147/DMSO.S234563
PMID:32547148
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7266524/
Abstract

BACKGROUND

Increase in the prevalence of type 2 diabetic mellitus (T2DM) as a complex disease, its complications, and spread has become a dominant global health threat in recent decades.

OBJECTIVE

The aim of the current study was to investigate the impact of risk factors and transition probability on the development and progression of the late complications of T2DM.

METHODS

This study was an open cohort one which was conducted at Isfahan Endocrine and Metabolism Research Center (IEMRC). The data were collected from 1993 to 2018. The sample size consisted of 2519 adults diagnosed with type 2 diabetes. We applied the homogeneous multistate models including no complication, retinopathy alone, coronary artery disease (CAD), microalbuminuria, retinopathy and CAD, and the final absorbing mortality states.

RESULTS

Based on our results, time-varying hypertension strongly intensified the hazard of transition to mortality in CAD, no complication, CAD and retinopathy, and retinopathy patients by 4.99, 4.09, 3.42, and 2.65 times, respectively. Hypertension seemed to be a potential factor for the transition of microalbuminuria to no complication in diabetic patients. One-unit increase in LDL increased the hazard ratio of transition from CAD, and retinopathy and CAD to mortality by 1.8% and 2.4%, respectively. Moreover, one level increase in time-varying HbA1c increased the hazard ratio of transition to retinopathy and mortality among no complication diabetic patients by 30% and 67%, respectively. One level increase in time-varying HbA1c also intensified the hazard ratio of transition from retinopathy to mortality by 45%. The same level of increase in time-varying HbA1c also intensified the hazard ratio of transition from CAD alone to CAD and retinopathy, and microalbuminuria to retinopathy by 26% and 50%, respectively.

CONCLUSION

In addition to glycemic control, our study indicates that controlling hypertension and hyperlipidemia is more effective in reducing mortality and the diabetic macro- and microvascular complications.

摘要

背景

近几十年来,2型糖尿病(T2DM)作为一种复杂疾病,其患病率、并发症及传播范围的增加已成为全球主要的健康威胁。

目的

本研究旨在探讨危险因素和转移概率对T2DM晚期并发症发生和发展的影响。

方法

本研究是一项在伊斯法罕内分泌与代谢研究中心(IEMRC)开展的开放队列研究。数据收集时间为1993年至2018年。样本量包括2519名被诊断为2型糖尿病的成年人。我们应用了同质多状态模型,包括无并发症、单纯视网膜病变、冠状动脉疾病(CAD)、微量白蛋白尿、视网膜病变和CAD,以及最终的吸收性死亡状态。

结果

根据我们的研究结果,随时间变化的高血压分别使CAD、无并发症、CAD和视网膜病变以及视网膜病变患者向死亡转移的风险显著增加4.99倍、4.09倍、3.42倍和2.65倍。高血压似乎是糖尿病患者微量白蛋白尿向无并发症转变的一个潜在因素。低密度脂蛋白(LDL)每增加一个单位,从CAD以及视网膜病变和CAD向死亡转移的风险比分别增加1.8%和2.4%。此外,随时间变化的糖化血红蛋白(HbA1c)每升高一个水平,无并发症糖尿病患者向视网膜病变和死亡转移的风险比分别增加30%和67%。随时间变化的HbA1c每升高一个水平,从视网膜病变向死亡转移的风险比也增加45%。随时间变化的HbA1c相同程度的升高还分别使从单纯CAD向CAD和视网膜病变转移以及从微量白蛋白尿向视网膜病变转移的风险比增加26%和50%。

结论

除血糖控制外,我们的研究表明,控制高血压和高脂血症在降低死亡率以及糖尿病大血管和微血管并发症方面更有效。

相似文献

1
Multistate Models to Predict Development of Late Complications of Type 2 Diabetes in an Open Cohort Study.在一项开放性队列研究中预测2型糖尿病晚期并发症发生情况的多州模型
Diabetes Metab Syndr Obes. 2020 May 28;13:1863-1872. doi: 10.2147/DMSO.S234563. eCollection 2020.
2
Microalbuminuria as the Tip of Iceberg in Type 2 Diabetes Mellitus: Prevalence, Risk Factors, and Associated Diabetic Complications.微量白蛋白尿:2型糖尿病的冰山一角——患病率、危险因素及相关糖尿病并发症
Cureus. 2023 Aug 9;15(8):e43190. doi: 10.7759/cureus.43190. eCollection 2023 Aug.
3
Neutrophil-lymphocyte Ratio is a Novel Reliable Predictor of Nephropathy, Retinopathy, and Coronary Artery Disease in Indians with Type-2 Diabetes.中性粒细胞与淋巴细胞比值是印度2型糖尿病患者肾病、视网膜病变和冠状动脉疾病的一种新型可靠预测指标。
Indian J Endocrinol Metab. 2017 Nov-Dec;21(6):864-870. doi: 10.4103/ijem.IJEM_197_17.
4
Relationship between diabetic retinopathy microalbuminuria and other modifiable risk factors.糖尿病视网膜病变微量白蛋白尿与其他可改变的危险因素的关系。
Prim Care Diabetes. 2021 Jun;15(3):567-570. doi: 10.1016/j.pcd.2021.01.012. Epub 2021 Feb 4.
5
[Chronic complications and risk factors in patients with type 1 diabetes mellitus--retrospective analysis].1型糖尿病患者的慢性并发症及危险因素——回顾性分析
Przegl Lek. 2003;60(12):773-7.
6
Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.对1型糖尿病患者样本进行15年随访研究后的肾脏和视网膜微血管病变
J Diabetes Complications. 2007 Mar-Apr;21(2):93-100. doi: 10.1016/j.jdiacomp.2006.04.001.
7
Metabolic Syndrome in Type 2 Diabetes Mellitus Patients: Prevalence, Risk Factors, and Associated Microvascular Complications.2型糖尿病患者的代谢综合征:患病率、危险因素及相关微血管并发症
Cureus. 2023 May 16;15(5):e39076. doi: 10.7759/cureus.39076. eCollection 2023 May.
8
Early Diabetic Nephropathy and Retinopathy in Patients with Type 1 Diabetes Mellitus Attending Sudan Childhood Diabetes Centre.1 型糖尿病患儿在苏丹儿童糖尿病中心就诊时的早期糖尿病肾病和视网膜病变。
J Diabetes Res. 2020 Nov 24;2020:7181383. doi: 10.1155/2020/7181383. eCollection 2020.
9
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.增生性糖尿病性视网膜病变在糖尿病性视网膜病变患者中发展和进展的预测因素。
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.
10
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.

引用本文的文献

1
Cost-effectiveness of a digital supportive healthcare pathway for type 2 diabetes compared to usual care in Belgium.与比利时常规护理相比,2型糖尿病数字支持性医疗路径的成本效益。
Digit Health. 2025 Feb 26;11:20552076251319169. doi: 10.1177/20552076251319169. eCollection 2025 Jan-Dec.
2
Modeling of Disease Progression of Type 2 Diabetes Using Real-World Data: Quantifying Competing Risks of Morbidity and Mortality.利用真实世界数据对2型糖尿病疾病进展进行建模:量化发病和死亡的竞争风险
CPT Pharmacometrics Syst Pharmacol. 2025 Mar;14(3):606-615. doi: 10.1002/psp4.13301. Epub 2025 Jan 17.
3
Building a multistate model from electronic health records data for modeling long-term diabetes complications.

本文引用的文献

1
Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease.收缩压和舒张压变异性与终末期肾病风险的关系。
Hypertension. 2019 Oct;74(4):880-887. doi: 10.1161/HYPERTENSIONAHA.119.13422. Epub 2019 Aug 19.
2
Cross-sectional and longitudinal assessments of risk factors associated with hypertension and moderately increased albuminuria comorbidity in patients with type 2 diabetes: a 9-year open cohort study.2型糖尿病患者高血压与中度白蛋白尿合并症相关危险因素的横断面和纵向评估:一项9年的开放队列研究
Diabetes Metab Syndr Obes. 2019 Jul 15;12:1123-1139. doi: 10.2147/DMSO.S189726. eCollection 2019.
3
利用电子健康记录数据构建多状态模型以模拟长期糖尿病并发症。
J Clin Transl Sci. 2024 Sep 23;8(1):e133. doi: 10.1017/cts.2024.583. eCollection 2024.
4
Type 2 diabetes mellitus aggravates coronary atherosclerosis in hypertensive individuals based on coronary CT angiography: a retrospective propensity score-based study.基于冠状动脉CT血管造影的回顾性倾向评分研究:2型糖尿病加重高血压患者的冠状动脉粥样硬化
Front Cardiovasc Med. 2024 May 20;11:1372519. doi: 10.3389/fcvm.2024.1372519. eCollection 2024.
5
Adherence to diabetes quality indicators in primary care and all-cause mortality: A nationwide population-based historical cohort study.基层医疗中糖尿病质量指标的遵循情况与全因死亡率:一项全国范围内基于人群的历史队列研究。
PLoS One. 2024 May 9;19(5):e0302422. doi: 10.1371/journal.pone.0302422. eCollection 2024.
6
Zuogui Jiangtang Shuxin formula Ameliorates diabetic cardiomyopathy mice modulating gut-heart axis.左归降糖舒心方通过调节肠-心轴改善糖尿病心肌病小鼠。
Front Endocrinol (Lausanne). 2023 Feb 9;14:1106812. doi: 10.3389/fendo.2023.1106812. eCollection 2023.
Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis.
伊朗人群2型糖尿病的并发症:一项最新的系统评价和荟萃分析。
Diabetes Metab Syndr. 2019 May-Jun;13(3):2300-2312. doi: 10.1016/j.dsx.2019.05.018. Epub 2019 May 23.
4
Impact of chrysin on the molecular mechanisms underlying diabetic complications.白杨素对糖尿病并发症相关分子机制的影响。
J Cell Physiol. 2019 Aug;234(10):17144-17158. doi: 10.1002/jcp.28488. Epub 2019 Mar 27.
5
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program).2 型糖尿病患者的血管并发症:38 个国家的患病率和相关因素(DISCOVER 研究项目)。
Cardiovasc Diabetol. 2018 Nov 28;17(1):150. doi: 10.1186/s12933-018-0787-8.
6
Relationship between dyslipidemia and diabetic retinopathy: A systematic review and meta-analysis.血脂异常与糖尿病视网膜病变之间的关系:一项系统评价与荟萃分析。
Medicine (Baltimore). 2018 Sep;97(36):e12283. doi: 10.1097/MD.0000000000012283.
7
Development of Microvascular Complications and Effect of Concurrent Risk Factors in Type 1 Diabetes: A Multistate Model From an Observational Clinical Cohort Study.1 型糖尿病微血管并发症的发展及并发危险因素的影响:一项来自观察性临床队列研究的多状态模型。
Diabetes Care. 2018 Nov;41(11):2297-2305. doi: 10.2337/dc18-0679. Epub 2018 Aug 21.
8
Prevalence of Chronic Complications, Their Risk Factors, and the Cardiovascular Risk Factors among Patients with Type 2 Diabetes Attending the Diabetic Clinic at a Tertiary Care Hospital in Sri Lanka.斯里兰卡一家三级护理医院糖尿病诊所患者的慢性并发症患病率、其危险因素,以及心血管危险因素。
J Diabetes Res. 2018 May 23;2018:4504287. doi: 10.1155/2018/4504287. eCollection 2018.
9
The Evidence for an Obesity Paradox in Type 2 Diabetes Mellitus.2型糖尿病中肥胖悖论的证据
Diabetes Metab J. 2018 Jun;42(3):179-187. doi: 10.4093/dmj.2018.0055. Epub 2018 May 31.
10
Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria.用于预测 2 型糖尿病合并微量白蛋白尿患者死亡率的尿蛋白质组学。
Cardiovasc Diabetol. 2018 Apr 6;17(1):50. doi: 10.1186/s12933-018-0697-9.